In a new spin on the concept of the FDA's 'revolving door', Vinay Prasad is back as head of the Center for Biologics Evaluation and Research (CBER), just over a week after he left the role. The word ...
Vinay Prasad has stepped down as head of the FDA's Center for Biologics Evaluation and Research (CBER), less than three months after taking on the role. His departure – first reported by STAT and now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback